An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease

Journal of the Neurological Sciences

Volumn 148, Issue 2, 1997, Pages 181-186

  Yoritaka, Asako ^a   Hattori, Nobutaka ^a   Mori, Hideo ^a   Kato, Kanefusa ^b   Mizuno, Yoshikuni ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

Free radicals; Mn superoxide dismutase; Oxidative stress; Parkinson's disease; Pathogenesis

Indexed keywords

FREE RADICAL; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; FEMALE; FREE RADICALS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURONS; OCULOMOTOR NERVE; OXIDATIVE STRESS; PARKINSON DISEASE; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE;

EID: 0031589982     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)05339-7     Document Type: Article

References (26)

1. Beckman, J.S., Beckman, T.W. and Chen, J., et al. (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA, 87: 1620-4.
2. Ben-Shachar, D., Riederer, P. and Youdim, M.B. (1991) Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease. J. Neurochem., 57: 1609-1614.
3. Boveris, A. (1977) Mitochondrial production of superoxide radical and hydrogen peroxide. Adv. Exp. Med., 10: 161-169.
4. Cleeter, M.W., Cooper, J.M. and Schapira, A.H. (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement. J. Neurochem., 58: 786-789.
5. Dexter, D.T., Carter, C.J. and Wells, F.R., et al. (1989a) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem., 52: 381-389.
6. Dexter, D.T., Wells, F.R. and Lees, A.J., et al. (1989b) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem., 52: 1830-1836.
7. Good, P.F., Olanow, C.W. and Perl, D.P. (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study. Brain Res., 593: 343-346.
8. Halliwell, B. (1989) Oxidants and the central nervous system: Some fundamental questions. Acta Neurol. Scand., 126: 23-33.
9. Hattori, N., Tanaka, M., Ozawa, T. and Mizuno, Y. (1991) Immunohistochemical studies on complexes I, II, III and IV of mitochondria in Parkinson's disease. Ann. Neurol., 30: 563-571.
10. Jellinger, K., Kienzl, E. and Rumpelmair, G., et al. (1992) Iron-melanin complex in substantia nigra of Parkinsonian brains: An X-ray microanalysis. J. Neurochem., 59: 1168-1171.
11. Jenner, P., Dexter, D.T. and Sian, J., et al. (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol., 32: S82-S87.
12. Kurobe, N., Inagaki, T. and Kato, K. (1990) Sensitive enzyme immunoassay for human Mn superoxide dismutase. Clin. Chim. Acta, 192: 171-179.
13. Marttila, R.J., Lorentz, H. and Rinne, U.K. (1988) Oxygen toxicity protecting enzymes in the Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J. Neurol. Sci., 86: 321-331.
14. McCord, J.M. (1988) Free radicals and myocardial ischemia: Overview and outlook. Free Radic. Biol. Med., 4: 9-14.
15. Mizuno, Y., Ohta, S. and Tanaka, M., et al. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun., 163: 1450-1455.
16. Mizuno, Y., Sone, N. and Saitoh, T. (1986) Dopaminergic neurotoxins, MPTPand MPP+, inhibit mitochondrial NADH-ubiquinone oxidoreductase activity. Proc. Jpn. Acad. (Ser. b), 62: 261-263.
17. Nicklas, W.J., Vyas, I. and Heikkika, R.E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci., 36: 2503-2508.
18. Perry, T.L., Godin, D.V. and Hansen, S. (1982) Parkinson's disease: A disorder due to nigral glutathione deficiency? Neurosci. Lett., 33: 305-310.
19. Poirier, J., Dea, D., Baccichet, A. and Thiffault, C. (1994) Superoxide dismutase expression in Parkinson's disease. Ann. NY Acad. Sci., 738: 116-120.
20. Ramsay, R.R. and Singer, T.P. (1986) Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, by mitochondria. J. Biol. Chem., 261: 7585-7587.
21. Riederer, P., Sofic, E. and Rausch, W.D., et al. (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J. Neurochem., 52: 515-520.
22. Saggu, H., Cooksey, J. and Dexter, D., et al. (1989) A selective increase in particulate superoxide dismutase activity in Parkinsonian substantia nigra. J. Neurochem, 53: 692-697.
23. Schapira, A.H., Cooper, J.M. and Dexter, D., et al. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet, 1: 1269.
24. Sian, J., Dexter, D.T. and Lees, A.J., et al. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol, 36: 348-355.
25. Yoritaka, A., Hattori, N. and Uchida, K., et al. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease. Proc. Natl. Acad. Sci. USA, 93: 2696-2701.
26. Zhang, Y., Marcillat, O. and Giulivi, C., et al. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem., 265: 16330-16336.